MOH Stock Analysis — Molina Healthcare
Sector: Healthcare
AI Verdict
Molina trades at 38.9x next year's earnings while analysts expect a -40.8% drop in EPS, so you're paying a premium the numbers don't yet support unless its Medicaid contract moat delivers a sharp rebound.
Competitive Moat
Molina Healthcare specializes in managing government-sponsored health plans, particularly Medicaid and Medicare, leveraging deep regulatory expertise and local provider networks. Its defensibility comes from entrenched relationships with state agencies and the complexity of Medicaid contract bidding, which creates high switching costs for states and members.
Summary
A sharp drop in expected earnings (-40.8% forward EPS growth) is driving a huge jump in Molina’s forward P/E multiple.
Where It Stands
Shares are up 15.59% over the past year, with an RSI of 56.5 indicating a neutral stance, but the stock now trades at 38.9x next year's earnings—well above the healthcare sector median of 22x.
Key Metrics
- RSI: 56.5 — Neutral
- Trailing P/E: 23.0x
- Forward P/E: 38.9x
- Earnings Growth: -0.4%
- Revenue Growth: +0.0%
- Market Cap: $10.5B
- 1-Year Return: 15.59%
- 52-Week High: $244.89
- 52-Week Low: $121.06
Analyst Consensus
7 Buy · 17 Hold · 1 Sell (25 analysts)
Bull Case
The trailing P/E of 23.0x is in line with sector norms, reflecting the market's trust in Molina’s Medicaid contract moat and its ability to weather short-term earnings volatility.
Bear Case
If the forward P/E compresses from 38.9x back toward the sector median of 22x, the stock could see a 43% valuation drop even before accounting for the -40.8% EPS decline expected next year.
Catalyst to Watch
Watch for upcoming state Medicaid contract awards or renewals—winning or losing a major contract will directly impact the earnings outlook and justify or undermine the current premium.